# Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease

> **NCT02216877** · PHASE1,PHASE2 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 36 (actual)

## Conditions studied

- Chronic Kidney Disease
- Hypomagnesemia

## Interventions

- **DRUG:** Mablet 360 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02216877
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216877, "Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02216877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*